These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2230735)

  • 21. Development and Characterization of Monoclonal Antibodies to Yellow Fever Virus and Application in Antigen Detection and IgM Capture Enzyme-Linked Immunosorbent Assay.
    Adungo F; Yu F; Kamau D; Inoue S; Hayasaka D; Posadas-Herrera G; Sang R; Mwau M; Morita K
    Clin Vaccine Immunol; 2016 Aug; 23(8):689-97. PubMed ID: 27307452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Host-cell interaction of attenuated and wild-type strains of yellow fever virus can be differentiated at early stages of hepatocyte infection.
    Lefeuvre A; Contamin H; Decelle T; Fournier C; Lang J; Deubel V; Marianneau P
    Microbes Infect; 2006 May; 8(6):1530-8. PubMed ID: 16697681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural and Nonstructural Genes Contribute to the Genetic Diversity of RNA Viruses.
    Collins ND; Beck AS; Widen SG; Wood TG; Higgs S; Barrett ADT
    mBio; 2018 Oct; 9(5):. PubMed ID: 30377281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variation in the biological function of envelope protein epitopes of yellow fever vaccine viruses detected with monoclonal antibodies.
    Ledger TN; Sil BK; Wills MR; Lewis G; Kinney RM; Jennings AD; Stephenson JR; Barrett AD
    Biologicals; 1992 Jun; 20(2):117-28. PubMed ID: 1389107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses.
    Brandriss MW; Schlesinger JJ; Walsh EE; Briselli M
    J Gen Virol; 1986 Feb; 67 ( Pt 2)():229-34. PubMed ID: 3944585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction and biological properties of yellow fever 17D/dengue type 1 recombinant virus.
    Mateu GP; Marchevsky RS; Liprandi F; Bonaldo MC; Coutinho ES; Dieudonné M; Caride E; Jabor AV; Freire MS; Galler R
    Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):289-98. PubMed ID: 17169387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypic analysis of yellow fever virus derived from complementary DNA.
    Marchevsky RS; Mariano J; Ferreira VS; Almeida E; Cerqueira MJ; Carvalho R; Pissurno JW; da Rosa AP; Simoes MC; Santos CN
    Am J Trop Med Hyg; 1995 Jan; 52(1):75-80. PubMed ID: 7856829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological characterization of plaque-size variants of yellow fever virus in mosquitoes and mice.
    Miller BR; Adkins D
    Acta Virol; 1988 May; 32(3):227-34. PubMed ID: 2902770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity.
    Freire MS; Mann GF; Marchevsky RS; Yamamura AM; Almeida LF; Jabor AV; Malachias JM; Coutinho ES; Galler R
    Vaccine; 2005 Mar; 23(19):2501-12. PubMed ID: 15752837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of 17D yellow fever virus envelope protein epitopes using monoclonal antibodies.
    Schlesinger JJ; Walsh EE; Brandriss MW
    J Gen Virol; 1984 Oct; 65 ( Pt 10)():1637-44. PubMed ID: 6208313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of administration of sodium aurothiomalate on the virulence of yellow fever viruses in adult mice.
    Gibson CA; Wills MR; Gould EA; Sanders PG; Barrett AD
    Vaccine; 1990 Dec; 8(6):590-4. PubMed ID: 2128429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-mediated early death in vivo after infection with yellow fever virus.
    Barrett AD; Gould EA
    J Gen Virol; 1986 Nov; 67 ( Pt 11)():2539-42. PubMed ID: 3783130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuation and immunogenicity of recombinant yellow fever 17D-dengue type 2 virus for rhesus monkeys.
    Galler R; Marchevsky RS; Caride E; Almeida LF; Yamamura AM; Jabor AV; Motta MC; Bonaldo MC; Coutinho ES; Freire MS
    Braz J Med Biol Res; 2005 Dec; 38(12):1835-46. PubMed ID: 16302098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice.
    Ryman KD; Xie H; Ledger TN; Campbell GA; Barrett AD
    Virology; 1997 Apr; 230(2):376-80. PubMed ID: 9143294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of foreign protein epitopes at the surface of recombinant yellow fever 17D viruses based on three-dimensional modeling of its envelope protein.
    Bonaldo MC; Garratt RC; Freire MS; Galler R
    Cell Biochem Biophys; 2006; 44(3):313-24. PubMed ID: 16679518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice.
    Gould EA; Buckley A; Barrett AD; Cammack N
    J Gen Virol; 1986 Mar; 67 ( Pt 3)():591-5. PubMed ID: 3950582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation in NS5 protein attenuates mouse neurovirulence of yellow fever 17D vaccine virus.
    Xie H; Ryman KD; Campbell GA; Barrett AD
    J Gen Virol; 1998 Aug; 79 ( Pt 8)():1895-9. PubMed ID: 9714237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoblotting reveals differences in the accumulation of envelope protein by wild-type and vaccine strains of yellow fever virus.
    Cane PA; Gould EA
    J Gen Virol; 1989 Mar; 70 ( Pt 3)():557-64. PubMed ID: 2732701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus.
    Bonaldo MC; Garratt RC; Caufour PS; Freire MS; Rodrigues MM; Nussenzweig RS; Galler R
    J Mol Biol; 2002 Jan; 315(4):873-85. PubMed ID: 11812154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mouse model for studying viscerotropic disease caused by yellow fever virus infection.
    Meier KC; Gardner CL; Khoretonenko MV; Klimstra WB; Ryman KD
    PLoS Pathog; 2009 Oct; 5(10):e1000614. PubMed ID: 19816561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.